Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.,Ltd (SHE:301130)

Market Cap	2.31B +15.6%
Revenue (ttm)	234.84M -8.4%
Net Income	21.90M -45.6%
EPS	0.29 -44.7%
Shares Out	75.49M
PE Ratio	106.71
Forward PE	n/a
Dividend	0.26 (0.81%)
Ex-Dividend Date	May 29, 2025

Volume	1,937,123
Average Volume	1,516,843
Open	31.56
Previous Close	32.25
Day's Range	30.40 - 32.79
52-Week Range	27.13 - 36.98
Beta	0.53
RSI	42.44
Earnings Date	Apr 29, 2026

About SHE:301130

Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.,Ltd engages in the research and development, production, and sales of chemical raw materials and pharmaceutical preparations in China. The company provides drugs for the treatment of anemia, mental disorders, anti-psychotic disorders, cardiovascular and cerebrovascular diseases, and tumors. It provides drugs in the form of tablets and capsules. The company was founded in 1990 and is headquartered in Panshi, China.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1990
• Employees: 320
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 301130

Financial Performance

In 2025, SHE:301130's revenue was 234.84 million, a decrease of -8.41% compared to the previous year's 256.41 million. Earnings were 21.90 million, a decrease of -45.62%.